Frequency and distribution of NF2 mutations in schwannomas

Genes Chromosomes and Cancer

Volumn 17, Issue 1, 1996, Pages 45-55

  Jacoby, Lee B ^a,b   MacCollin, Mia ^b   Barone, Rosemary ^a   Ramesh, Vijaya ^b   Gusella, James F ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 22Q; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEURILEMOMA; NONSENSE MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN, PAIR 22; EXONS; FEMALE; GENES, NEUROFIBROMATOSIS 2; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NEURILEMMOMA; NEUROFIBROMIN 2; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0029794048     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2     Document Type: Article

References (34)

1. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y (1994) Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3:565-568.
2. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N (1994) Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 6:185-192.
3. Bianchi AB, Mitsunaga S, Cheng JQ, Klein WM, Jhanwar SC, Seizinger BS, Kley N, Klein-Szanto AJP, Testa JR (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in human malignant mesothelioma. Proc Natl Acad Sci USA 92:10854-10858.
4. Bijlsma EK, Mérel P, Andries Bosch D, Westerveld A, Delattre O, Thomas G, Hulsebos TJM (1994) Analysis of mutations in the SCH gene in schwannomas. Genes Chromosom Cancer 11:7-14.
5. Bourn D, Strachan T (1995) Highly polymorphic dinucleotide repeat at the NF2 gene. Hum Genet 95:712.
6. Bourn D, Carter SA, Mason S, Evans DGR, Strachan T (1994) Germline mutations in neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet 3:813-816.
7. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 304:603-618.
8. Funayama N, Nagafuchi A, Sato N, Tsukita S, Tsukita S (1991) Radixin is a novel member of the band 4.1 family. J Cell Biol 115:1039-1048.
9. Gould KL, Bretscher A, Esch FS, Hunter T (1989) cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J 8:4133-4142.
10. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER (1994) Somatic NF2 gene mutations in familial and nonfamilial vestibular schwannoma. Hum Mol Genet 3:347-350.
11. Jacoby LB, MacCollin MM, Louis DN, Mohney T, Rubio M-P, Pulaski K, Trofatter JA, Kley N, Seizinger BR, Ramesh V, Gusella JF (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419.
12. Lankes WT, Furthmayr H (1991) Moesin: A member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 88: 8297-8301.
13. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwartoff EC (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029.
14. MacCollin M, Ramesh V, Jacoby LB, Louis DN, Rubio M-P, Pulaski K, Trofatter JA, Short MP, Bove C, Eldridge R, Parry DM, Gusella JF (1994) Mutational analysis of patients with neurofibromatosis 2. Am J Hum Genet 55:314-320.
15. MacCollin M, Woodfin W, Kronn D, Short MP (1996) Schwannomatosis: A clinical and pathological study. Neurology 46:1072-1079.
16. Marineau C, Baron C, Delattre O, Zucman J, Thomas G, Rouleau GA (1993) Dinucleotide repeat polymorphism at the D22S268 locus. Hum Mol Genet 2:336.
17. Mérel P, Hoang-Xuan K, Sanson M, Bijlsma EK, Laurent-Puig P. Pulst SM, Rouleau GA, Lenoir GM, Sterkers JM, Philippon J, Resche F, Mautner V, Fischer G, Hulsebos TJM, Aurias A, Delattre O, Thomas G (1995a) Screening for germline mutations in the NF2 gene. Genes Chromosom Cancer 12:117-127.
18. Mérel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G (1995b) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 13:211-216.
19. Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI, Eldridge R (1990) Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): An update. Ann Intern Med 113:39-52.
20. Pykett MJ, Murphy M, Harnish PR, George DL (1994) The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet 3:559-564.
21. Rouleau GA, Mérel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir GM, Bijlsma EK, Fashold R, Dumanski JP, de Jong P, Parry DM, Eldridge R, Aurias A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
22. Rubio M-P, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN (1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54:45-47.
23. Rustgi AK, Pinney D, Sterner C, Beauchamp R, Schmidt S, Gusella JF, Ramesh V (1995) The neurofibromatosis 2 gene in human colorectal cancer. Cancer Genet Cytogenet 84:24-26.
24. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Mérel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA (1994) Evidence for the complete inactivation of the NFZ gene in the majority of sporadic meningiomas. Nature Genet 6:180-184.
25. Sainz J, Nechiporuk A, Kim U-J, Simon MI, Pulst SM (1993) CA-repeat polymorphism at the D22430 locus adjacent to NF2. Hum Mol Genet 2:2203.
26. Sainz J, Huynh DP, Figueroa K, Baser ME, Pulst SM (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-891.
27. Sainz J, Figueroa K, Baser ME, Mautner VF, Pulst SM (1995) High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons. Hum Mol Genet 4:137-139.
28. Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644-647.
29. Sekido Y, Pass HI, Bader S, Mew DJY, Christman MF, Gazdar AF, Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227-1231.
30. Short MP, Martuza RL, Huson SM (1994) Neurofibromatosis 2: Clinical features, genetic counselling and management issues. In Huson SM, Hughes RAC (eds): The Neurofibromatoses: A Pathogenetic and Clinical Overview. London: Chapman and Hall, pp 414-444.
31. Trofatter JA, MacCollin M, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
32. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Mérel P, Delattre O, Thomas G, Rouleau GA (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151.
33. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseiz G, Lathrop M (1992) A second-generation linkage map of the human genome. Nature 359:794-801.
34. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Diemling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1246:827-832.